Rebecca Sykes

Health care Biotech Innovation Brand Economic cycle Equity Global Industry Research Article Outlook

Health care outlook for 2023

Looking ahead to 2023, members of our health care team see meaningful innovation, supportive valuations, and a benign political and regulatory backdrop across biopharma, medical tech, and health care services sectors.

Multiple authors

event December 2022

Article

2023-12-31

Health care Innovation Global Industry Research Equity Subadvisory Discretionary Video

The next generation of pharmaceutical innovation

Rebecca Sykes explores the exciting innovations she sees in the pharmaceutical industry today, including antibody drug conjugates, gene editing, obesity treatments, and much more.

By

Rebecca Sykes, CFA

event September 2022

Video

2023-09-30

iStrat Biotech Disruption About us Machine learning WELLSaid Podcast Brand Podcast

The future of health care - Part 2: Groundbreaking pharma

Global Industry Analyst Rebecca Sykes joins host Thomas Mucha to discuss the future of the pharmaceutical industry. They highlight the impacts of COVID-19 on the industry and explore today's newest pharma innovations, such as treatments for cancer, obesity, and more.

By

Rebecca Sykes, CFA

event August 2022

32:12 min

Podcast

Contact us

Explore our insights

Asset class

Key Topics

Formats

2025 Investment Outlook

Asset Classes

Investment Solutions

Sustainable Investing

Stewardship Principles

Investment Solutions

Corporate Sustainability

About us

Contact Us

Media & press

Careers

Unique Perspectives

Insights By Rebecca Sykes

legal Information

follow us